123 related articles for article (PubMed ID: 27538188)
1. Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial.
Isidean SD; Mayrand MH; Ramanakumar AV; Gilbert L; Reid SL; Rodrigues I; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
Int J Cancer; 2016 Dec; 139(11):2456-66. PubMed ID: 27538188
[TBL] [Abstract][Full Text] [Related]
2. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Robertson M; Castle PE;
Int J Cancer; 2014 Aug; 135(3):624-34. PubMed ID: 24226935
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
[TBL] [Abstract][Full Text] [Related]
4. Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States.
Wheeler CM; Torrez-Martinez NE; Torres-Chavolla E; Parvu V; Andrews JC; Du R; Robertson M; Joste NE; Cuzick J;
Am J Obstet Gynecol; 2024 Feb; 230(2):243.e1-243.e11. PubMed ID: 37806613
[TBL] [Abstract][Full Text] [Related]
5. Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women.
Johnson LG; Saidu R; Mbulawa Z; Williamson AL; Boa R; Tergas A; Moodley J; Persing D; Campbell S; Tsai WY; Wright TC; Denny L; Kuhn L
Cancer Med; 2020 Sep; 9(18):6813-6824. PubMed ID: 32706163
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of High-Risk HPV Detection and HPV Vaccination in Cervical Cancer Screening During the HPV Vaccination Era at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center.
Chaopotong P; Laiwejpithya S; Areeswate C
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1241-1245. PubMed ID: 38679983
[TBL] [Abstract][Full Text] [Related]
7. Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.
Stoler MH; Austin RM; Zhao C
J Clin Microbiol; 2015 Sep; 53(9):2798-804. PubMed ID: 25948606
[TBL] [Abstract][Full Text] [Related]
8. Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study.
Arrossi S; Paolino M; Laudi R; Gago J; Campanera A; Marín O; Falcón C; Serra V; Herrero R; Thouyaret L
Lancet Glob Health; 2019 Jun; 7(6):e772-e783. PubMed ID: 31097279
[TBL] [Abstract][Full Text] [Related]
9. Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.
Silver MI; Rositch AF; Phelan-Emrick DF; Gravitt PE
Cancer Causes Control; 2018 Jan; 29(1):43-50. PubMed ID: 29124542
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of negative cytology results correlated with a positive high-risk in the human papillomavirus result and subsequent results of patients over a period of three years.
Piotrowski PG; Jeleń MT
Pol J Pathol; 2024; 75(1):36-39. PubMed ID: 38741427
[TBL] [Abstract][Full Text] [Related]
11. Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru.
Almonte M; Ferreccio C; Luciani S; Gonzales M; Delgado JM; Santos C; Alvarez M; Cuzick J; Sasieni P
PLoS One; 2015; 10(1):e0115355. PubMed ID: 25635965
[TBL] [Abstract][Full Text] [Related]
12. Variation in cervical cancer screening test utilization and results in a United States-based program.
Dorismond VG; Saraiya M; Gopalani SV; Soman A; Kenney K; Miller J; Sawaya GF
Gynecol Oncol; 2024 May; 184():96-102. PubMed ID: 38301312
[TBL] [Abstract][Full Text] [Related]
13. Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina.
Arrossi S; Thouyaret L; Laudi R; Marín O; Ramírez J; Paolino M; Herrero R; Campanera A
Int J Cancer; 2015 Oct; 137(7):1709-18. PubMed ID: 25807897
[TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV primary compared to HR-HPV and liquid-based cytology co-testing.
Dombrowski C; Bourgain C; Ma Y; Meiwald A; Pinsent A; Weynand B; Turner KME; Huntington S; Adams EJ; Bogers J; Croes R; Sahebali S
Eur J Cancer Prev; 2024 May; 33(3):262-270. PubMed ID: 37933867
[TBL] [Abstract][Full Text] [Related]
15. Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China.
Zhang L; Xu XQ; Hu SY; Chen F; Zhang X; Pan QJ; Zhang WH; Feng RM; Dong L; Zhang Q; Ma JF; Sauvaget C; Zhao FH; Qiao YL; Sankaranarayanan R
Gynecol Oncol; 2018 Nov; 151(2):221-228. PubMed ID: 30269870
[TBL] [Abstract][Full Text] [Related]
16. HPV-based cervical cancer screening in Nicaragua: from testing to treatment.
Holme F; Maldonado F; Martinez-Granera OB; Rodriguez JM; Almendarez J; Slavkovsky R; Bansil P; Thomson KA; Jeronimo J; de Sanjose S
BMC Public Health; 2020 Apr; 20(1):495. PubMed ID: 32295562
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea.
Shin JY; Choi KS; Suh M; Park B; Jun JK
BMC Cancer; 2018 Aug; 18(1):810. PubMed ID: 30098592
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women.
Sangrajrang S; Laowahutanont P; Wongsena M; Muwonge R; Imsamran W; Ploysawang P; Basu P
J Med Screen; 2019 Dec; 26(4):212-218. PubMed ID: 31364471
[No Abstract] [Full Text] [Related]
19. An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
Tanaka LF; Schoffer O; Schriefer D; Schauberger G; Ikenberg H; Klug SJ
Eur J Cancer; 2024 Apr; 201():113915. PubMed ID: 38364626
[TBL] [Abstract][Full Text] [Related]
20. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Ogilvie GS; Smith LW; van Niekerk DJ; Khurshed F; Krajden M; Saraiya M; Goel V; Rimer BK; Greene SB; Hobbs S; Coldman AJ; Franco EL
Int J Cancer; 2013 Dec; 133(12):2934-43. PubMed ID: 23754203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
